{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:57:56Z","timestamp":1793717876114,"version":"4.6.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Evaluate outcomes and identify prognostic factors in congenital aniridia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Retrospective interventional case series of patients with congenital aniridia treated between 2012\u20132020. Ocular examination and surgical details were collected. Surgical failure was defined as disease progression or need for additional surgery for same\/related indication. Kaplan\u2013Meier survival curves, Wilcoxon test, and univariate and multivariate linear regression analyses were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Ninety-four patients with congenital aniridia presented at median 19.0\u00a0years. Two-thirds of patients underwent\u2009\u2265\u20091intraocular surgery, with average of 1.7\u2009\u00b1\u20092.3 surgeries\/eye. At final follow-up (median 4.0\u00a0years), 45% of eyes had undergone lensectomy. Aphakic eyes showed worse visual acuity (VA) than phakic or pseudophakic eyes. Glaucoma affected 52% of eyes, of which half required IOP-lowering surgery. Glaucoma drainage devices showed the highest success rate (71%) at 14.2\u2009\u00b1\u200915.4\u00a0years of follow-up. Keratopathy affected 65% of eyes and one-third underwent corneal surgery. Keratoprosthesis had the longest survival rates at 10-years (64% with 95% CI [32,84]). LogMAR VA at presentation and final follow-up were not statistically different. Half of patients were legally blind at final follow-up. Final VA was associated with presenting VA, glaucoma diagnosis, and cataract or keratopathy at presentation. Penetrating keratoplasty and keratoprosthesis implantation correlated with worse BCVA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Most aniridic patients in this large US-based cohort underwent at least 1 intraocular surgery. Cataract, glaucoma, and keratopathy were associated with worse VA and are important prognostic factors to consider when managing congenital aniridia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-022-02460-5","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T07:03:06Z","timestamp":1653462186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Clinical outcomes and visual prognostic factors in congenital aniridia"],"prefix":"10.1186","volume":"22","author":[{"given":"Adam","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzad I.","family":"Mian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda L.","family":"Bohnsack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"issue":"6","key":"2460_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3341\/kjo.2014.28.6.479","volume":"28","author":"JW Chang","year":"2014","unstructured":"Chang JW, et al. Congenital aniridia: Long-term clinical course, visual outcome, and pronostic factors. Korean J Ophthalmol. 2014;28(6):479\u201385.","journal-title":"Korean J Ophthalmol"},{"issue":"2","key":"2460_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1586\/17469899.2016.1152182","volume":"11","author":"M Samant","year":"2016","unstructured":"Samant M, et al. Congenital aniridia: Etiology, manifestations and management. Expert Rev Ophthalmol. 2016;11(2):135\u201344.","journal-title":"Expert Rev Ophthalmol"},{"issue":"9","key":"2460_CR3","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3390\/genes12091403","volume":"12","author":"DA Balikov","year":"2021","unstructured":"Balikov DA, Jacobson A, Prasov L. Glaucoma syndromes: insights into glaucoma genetics and pathogenesis from monogenic syndromic disorders. Genes (Basel). 2021;12(9):1403.","journal-title":"Genes (Basel)."},{"key":"2460_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jtos.2021.09.001","volume":"22","author":"L Latta","year":"2021","unstructured":"Latta L, et al. Pathophysiology of aniridia-associated keratopathy: Developmental aspects and unanswered questions. Ocul Surf. 2021;22:245\u201366.","journal-title":"Ocul Surf"},{"key":"2460_CR5","first-page":"305350","volume":"2014","author":"P Calv\u00e3o-Pires","year":"2014","unstructured":"Calv\u00e3o-Pires P, et al. Congenital aniridia: Clinic, genetics, therapeutics, and prognosis. Int Sch Res Notices. 2014;2014:305350.","journal-title":"Int Sch Res Notices"},{"issue":"2","key":"2460_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s13353-017-0426-1","volume":"59","author":"A Wawrocka","year":"2018","unstructured":"Wawrocka A, Krawczynski MR. The genetics of aniridia - simple things become complicated. J Appl Genet. 2018;59(2):151\u20139.","journal-title":"J Appl Genet"},{"key":"2460_CR7","doi-asserted-by":"crossref","unstructured":"Blanco-Kelly F, et al. Genetics and epidemiology of aniridia: updated guidelines for genetic study.\u00a0Arch Soc Esp Oftalmol (Engl Ed). 2021;96 Suppl 1:4\u201314.","DOI":"10.1016\/j.oftale.2021.02.002"},{"key":"2460_CR8","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/ejhg.2012.100","volume":"20","author":"M Hingorani","year":"2012","unstructured":"Hingorani M, Hanson I, van Heyningen V. Aniridia. Eur J Hum Genet. 2012;20:1011\u20137.","journal-title":"Eur J Hum Genet"},{"key":"2460_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1001\/archopht.1992.01080160081036","volume":"110","author":"RE Wiggins","year":"1992","unstructured":"Wiggins RE, Tomey KF. The results of glaucoma surgery in aniridia. Arch Ophthalmol. 1992;110:503\u20135.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"2460_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S1542-0124(12)70130-1","volume":"1","author":"KL Mayer","year":"2003","unstructured":"Mayer KL, et al. Keratopathy in congenital aniridia. Ocul Surf. 2003;1(2):74\u20139.","journal-title":"Ocul Surf"},{"issue":"7","key":"2460_CR11","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1097\/ICO.0b013e318281724a","volume":"32","author":"JJ Rixen","year":"2013","unstructured":"Rixen JJ, et al. Treatment of aniridia with Boston Type 1 Keratoprosthesis. Cornea. 2013;32(7):947\u201350.","journal-title":"Cornea"},{"key":"2460_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10792-013-9868-6","volume":"34","author":"R Almousa","year":"2014","unstructured":"Almousa R, Lake DB. Intraocular pressure control with Ahmed glaucoma drainage device in patients with cicatricial ocular surface disease-associated or aniridia-related glaucoma. Int Ophthalmol. 2014;34:753\u201360.","journal-title":"Int Ophthalmol"},{"key":"2460_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ajo.2014.05.009","volume":"158","author":"SI Hassanaly","year":"2014","unstructured":"Hassanaly SI, Talajic JC, Harissi-Dagher M. Outcomes following Boston Type 1 Keratoprosthesis implantation in aniridia patients at the University of Montreal. Am J Ophthalmol. 2014;158:270\u20136.","journal-title":"Am J Ophthalmol"},{"key":"2460_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12886-017-0503-6","volume":"17","author":"JD Wang","year":"2017","unstructured":"Wang JD, et al. Congenital aniridia with cataract: case series. BMC Ophthalmol. 2017;17:115.","journal-title":"BMC Ophthalmol"},{"key":"2460_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4274\/tjo.galenos.2019.07348","volume":"49","author":"GS Demirok","year":"2019","unstructured":"Demirok GS, et al. Short- and long-term results of glaucoma valve implantation for aniridia-related glaucoma: A case series and literature review. Turk J Ophthalmol. 2019;49:183\u20137.","journal-title":"Turk J Ophthalmol"},{"key":"2460_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ajo.2019.06.018","volume":"207","author":"Nascimento E Silva, R","year":"2019","unstructured":"Nascimento E Silva, R, et al. Glaucoma management in patients with aniridia and Boston Type 1 Keratoprosthesis. Am J Ophthalmol. 2019;207:258\u201367.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"2460_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3928\/01913913-20090818-07","volume":"47","author":"H Lee","year":"2010","unstructured":"Lee H, et al. Complications and visual prognosis in children with aniridia. J Pediatr Ophthalmol Strabismus. 2010;47(4):205\u201310.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"5","key":"2460_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3341\/kjo.2010.24.5.291","volume":"24","author":"SH Park","year":"2010","unstructured":"Park SH, et al. Clinical features of Korean patients with congenital aniridia. Korean J Ophthalmol. 2010;24(5):291\u20136.","journal-title":"Korean J Ophthalmol"},{"key":"2460_CR19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jaapos.2011.07.009","volume":"15","author":"PA Netland","year":"2011","unstructured":"Netland PA, et al. Ocular and systemic findings in a survey of aniridia subjects. J AAPOS. 2011;15:562\u20136.","journal-title":"J AAPOS"},{"issue":"1","key":"2460_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3928\/01913913-20131223-01","volume":"51","author":"B Singh","year":"2014","unstructured":"Singh B, et al. Clinical manifestations of congenital aniridia. J Pediatr Ophthalmol Strabismus. 2014;51(1):59\u201362.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"1","key":"2460_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00417-008-0926-0","volume":"247","author":"C Lange","year":"2009","unstructured":"Lange C, et al. Resolving the clinical acuity categories \u201chand motion\u201d and \u201ccounting fingers\u201d using the Freiburg Visual Acuity Test (FrACT). Graefes Arch Clin Exp Ophthalmol. 2009;247(1):137\u201342.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"2460_CR22","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1167\/iovs.05-0981","volume":"47","author":"K Schulze-Bonsel","year":"2006","unstructured":"Schulze-Bonsel K, et al. Visual Acuities \u201cHand Motion\u201d and \u201cCounting Fingers\u201d Can Be Quantified with the Freiburg Visual Acuity Test. Invest Ophthalmol Vis Sci. 2006;47(3):1236\u201340.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"2460_CR23","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00417-006-0474-4","volume":"245","author":"M Bach","year":"2007","unstructured":"Bach M. The Freiburg Visual Acuity Test-variability unchanged by post-hoc re-analysis. Graefes Arch Clin Exp Ophthalmol. 2007;245(7):965\u201371.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2460_CR24","first-page":"xii, 270","volume-title":"Childhood glaucoma : the 9th consensus report of the World Glaucoma Association. Consensus series","author":"RN Weinreb","year":"2013","unstructured":"Weinreb RN, et al. Childhood glaucoma\u202f: the 9th consensus report of the World Glaucoma Association. Consensus series. Amsterdam, The Netherlands: Kugler Publications; 2013. p. xii, 270."},{"issue":"1","key":"2460_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0161-6420(02)01451-3","volume":"110","author":"EJ Holland","year":"2003","unstructured":"Holland EJ, Djalilian AR, Schwartz GS. Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique. Ophthalmology. 2003;110(1):125\u201330.","journal-title":"Ophthalmology"},{"key":"2460_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajo.2019.11.003","volume":"210","author":"G Yazdanpanah","year":"2020","unstructured":"Yazdanpanah G, et al. Management of congenital aniridia-associated keratopathy: Long-term outcomes from a tertiary referral center. Am J Ophthalmol. 2020;210:8\u201318.","journal-title":"Am J Ophthalmol"},{"key":"2460_CR27","first-page":"5978293","volume":"2018","author":"GM Wang","year":"2018","unstructured":"Wang GM, et al. Phenotypic variation in a four-generation family with aniridia carrying a novel PAX6 mutation. J Ophthalmol. 2018;2018:5978293.","journal-title":"J Ophthalmol"},{"issue":"1","key":"2460_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/ICU.0b013e328333ea49","volume":"21","author":"IM Neuhann","year":"2010","unstructured":"Neuhann IM, Neuhann TF. Cataract surgery and aniridia. Curr Opin Ophthalmol. 2010;21(1):60\u20134.","journal-title":"Curr Opin Ophthalmol"},{"issue":"9","key":"2460_CR29","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1001\/archopht.117.9.1144","volume":"117","author":"TC Chen","year":"1999","unstructured":"Chen TC, Walton DS. Goniosurgery for prevention of aniridic glaucoma. Arch Ophthalmol. 1999;117(9):1144\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"2460_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00004397-200404410-00008","volume":"44","author":"JC Swanner","year":"2004","unstructured":"Swanner JC, Walton DS, Chen TC. Prevention of aniridic glaucoma with goniosurgery. Int Ophthalmol Clin. 2004;44(1):67\u201371.","journal-title":"Int Ophthalmol Clin"},{"issue":"7","key":"2460_CR31","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/IJG.0000000000000019","volume":"24","author":"A Jain","year":"2015","unstructured":"Jain A, et al. Aniridic glaucoma: Long-term visual outcomes and phenotypic associations. J Glaucoma. 2015;24(7):539\u201342.","journal-title":"J Glaucoma"},{"issue":"12","key":"2460_CR32","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/S0161-6420(97)30041-4","volume":"104","author":"M Adachi","year":"1997","unstructured":"Adachi M, et al. Clinical experience of trabeculotomy for the surgical treatment of aniridic glaucoma. Ophthalmology. 1997;104(12):2121\u20135.","journal-title":"Ophthalmology"},{"key":"2460_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0161-6420(98)91519-6","volume":"105","author":"DK Wallace","year":"1998","unstructured":"Wallace DK, et al. Surgical results of secondary glaucomas in childhood. Ophthalmology. 1998;105:101\u201311.","journal-title":"Ophthalmology"},{"issue":"5","key":"2460_CR34","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1091-8531(99)70028-5","volume":"3","author":"RH Taylor","year":"1999","unstructured":"Taylor RH, et al. The epidemiology of pediatric glaucoma: the Toronto experience. J AAPOS. 1999;3(5):308\u201315.","journal-title":"J AAPOS"},{"key":"2460_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ajo.2021.03.008","volume":"227","author":"I Durai","year":"2021","unstructured":"Durai I, et al. Outcomes of glaucoma drainage device implantation and trabeculectomy with mitomycin C in glaucoma secondary to aniridia. Am J Ophthalmol. 2021;227:173\u201381.","journal-title":"Am J Ophthalmol"},{"key":"2460_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0002-9394(02)01934-7","volume":"135","author":"CP Arroyave","year":"2002","unstructured":"Arroyave CP, et al. Use of glaucoma drainage devices in the management of glaucoma associated with aniridia. Am J Ophthalmol. 2002;135:155\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"2460_CR37","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1755-3768.2008.01427.x","volume":"86","author":"H Lee","year":"2008","unstructured":"Lee H, Khan R, O\u2019Keefe M. Aniridia: current pathology and management. Acta Ophthalmol. 2008;86(7):708\u201315.","journal-title":"Acta Ophthalmol"},{"issue":"5\u20136","key":"2460_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3109\/08820538.2013.825293","volume":"28","author":"HJ Lee","year":"2013","unstructured":"Lee HJ, Colby KA. A review of the clinical and genetic aspects of aniridia. Semin Ophthalmol. 2013;28(5\u20136):306\u201312.","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"2460_CR39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0002-9394(14)73581-0","volume":"115","author":"I Kremer","year":"1993","unstructured":"Kremer I, et al. Results of penetrating keratoplasty in aniridia. Am J Ophthalmol. 1993;115(3):317\u201320.","journal-title":"Am J Ophthalmol"},{"key":"2460_CR40","doi-asserted-by":"publisher","unstructured":"Bonneau S, et al. The treatment of end-stage corneal disease: penetrating keratoplasty compared with Boston type 1 keratoprosthesis. Graefes Arch Clin Exp Ophthalmol. 2022. https:\/\/doi.org\/10.1016\/j.oftale.2021.02.002. Epub 2021 Oct 22.","DOI":"10.1016\/j.oftale.2021.02.002"},{"key":"2460_CR41","doi-asserted-by":"publisher","first-page":"749063","DOI":"10.3389\/fmed.2021.749063","volume":"8","author":"A Dyer","year":"2021","unstructured":"Dyer A, et al. Long-Term Anatomical and Functional Survival of Boston Type 1 Keratoprosthesis in Congenital Aniridia. Front Med (Lausanne). 2021;8:749063.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"2460_CR42","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/wmh3.469","volume":"13","author":"JM Robillard","year":"2021","unstructured":"Robillard JM, Feng TL, Kabaci\u0144ska K. Access to genetic testing for rare diseases: Existing gaps in public-facing information. World Med Health Policy. 2021;13(3):518\u201325.","journal-title":"World Med Health Policy"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02460-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-022-02460-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02460-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T07:05:44Z","timestamp":1653462344000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-022-02460-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2460"],"URL":"https:\/\/doi.org\/10.1186\/s12886-022-02460-5","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"28 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was performed in accordance with the Declaration of Helsinki. As a retrospective study, this study was approved as exempt and obtaining informed consent from the patients was waived by the Institutional Review Board at the University of Michigan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}